Leading brain tumor experts meet for ReMission Summit 2023
Top neuro-oncology physicians and researchers from across the nation and abroad came together March 25-26 for the fifth annual ReMission Summit, a multidisciplinary gathering focused on discovering new treatments to change the future for patients with brain tumors. Attendees at the Rosen Shingle Creek in Orlando included survivors and families impacted by brain cancer, advocates devoted to raising awareness and scientists from foremost institutions in the U.S., Canada and England as well as virtual presenters from Germany, Switzerland and Australia.
Brain cancer experts unite for 2022 ReMission Summit
Brain cancer researchers, clinicians, survivors and supporters from across the U.S. and beyond united in person for the first time in more than two years for the 4th Annual ReMission Summit for Brain Tumors. While the COVID-19 pandemic didn’t halt the collaborative work of the UF Health-led ReMission Alliance Against Brain Tumors, and a virtual Summit filled the gap, the group embraced the opportunity to meet in person again with a hybrid format for the 2022 ReMission Summit, held March 19-21 at the Rosen Shingle Creek hotel in Orlando.
ReMission Summit 2021 Video Coverage
ReMission Summit 2020 Video Coverage
Leading brain tumor experts meet to advance UF Health-led ReMission Alliance
Every morning, Duane Mitchell, M.D., Ph.D., looks at an hourglass on his dresser given to him by the parents of University of Florida graduate and lacrosse captain Jamie Chapin, who died of brain cancer at age 25 in 2011. The hourglass serves as a daily reminder that time is running out for patients with malignant brain tumors and that the need is urgent to discover new treatments for a disease that has had stagnant survival rates for 30 years, even as rates for some other cancers such as leukemia have improved markedly. The weekend of Feb. 21-23, Mitchell and the UF brain tumor team he co-leads brought together expert investigators, physician-scientists and passionate supporters from across the U.S. and beyond to form new partnerships and collaborate in pursuit of discovering new immunotherapy regimens to improve quality of life and turn deadly brain cancers into livable diseases within 10 years. Representing 12 top academic medical centers, the experts belonging to the new UF Health-led ReMission Alliance Against Brain Tumors each accepted an hourglass like Mitchell’s, presented by Jamie Chapin’s parents.
12 leading medical centers unite to form brain tumor research collaborative
Today, the UF Health-led ReMission Alliance Against Brain Tumors announced the names of 12 partner institutions from across the U.S. and Canada that are teaming up to develop novel treatments to vastly improve quality of life and long-term survival for patients fighting malignant brain tumors. The announcement comes ahead of this weekend’s ReMission Summit for Brain Tumors, held at the Rosen Shingle Creek Hotel in Orlando, where internationally recognized neuro-oncologists and brain tumor investigators from the 12 partner institutions will form a one-of-a-kind research community for the advancement of brain tumor immunotherapy research and clinical trials.
ReMission Summit 2020 for Brain Tumor Researchers and Clinicians
Held Feb. 22-23, 2020 at the Rosen Shingle Creek Resort, Orlando Florida. The ReMission Summit is a workshop for leading brain tumor researchers and clinicians, industry innovators, and government neuro-oncology experts. Sponsored by University of Florida Trustee, Anita Zucker, and organized by leading neuro-oncology researcher Duane A. Mitchell, MD, PhD, this summit joins forces across disciplines, institutions, and the usual borders that all too often stymie effective research.
ReMission Alliance Against Brain Tumors
is announced on the Adam Michael Rosen Foundation website; On Friday, February 22, 2019, Harris Rosen and the ReMission Summit Against Brain Tumors officially announced a game changing alliance. During the 2019 summit at Rosen Shingle Creek, Mr. Rosen launched a fundraising campaign which he kicked off with a $12 million donation. Duane A. Mitchell, M.D., Ph.D., Director, Cancer Therapeutics & Immuno-Oncology at the University of Florida Health Cancer Center, says this partnership captures the desire for “a true paradigm shift in brain tumor research and treatment.”